Alembic Pharmaceuticals Limited(IN:APLLTD)
₹1,050.55-5.25 (-0.50%)
IN:APLLTD
Alembic Pharmaceuticals Limited financials statements
₹1,050.55
At close:-5.25 (-0.50%)
Want to see IN:APLLTD full AI Analyst Report?
Alembic Pharmaceuticals Limited (APLLTD) Income Statement
2 Followers
Alembic Pharmaceuticals Limited Income Statement
Last quarter (Q2 2027), Alembic Pharmaceuticals Limited's total revenue was ₹26.03B, an increase of 36.30% from the same quarter last year. In Q2, Alembic Pharmaceuticals Limited's net income was ₹3.35B. See Alembic Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 73.45B | ₹ 66.72B | ₹ 62.29B | ₹ 56.53B | ₹ 53.06B | |
| ₹ 33.10B | ₹ 47.91B | ₹ 44.33B | ₹ 38.78B | ₹ 38.08B | |
| ₹ 25.10B | ₹ 20.90B | ₹ 19.24B | ₹ 18.97B | ₹ 19.77B | |
| Depreciation and Amortization | ₹ 3.19B | ₹ 2.79B | ₹ 2.73B | ₹ 2.75B | ₹ 2.87B |
| ₹ 11.06B | ₹ 10.08B | ₹ 9.33B | ₹ 7.13B | ₹ 8.74B | |
| ₹ 8.00B | ₹ 27.02B | ₹ 25.08B | ₹ 19.81B | ₹ 18.31B | |
| ₹ -1.06B | ₹ -19.95B | ₹ -18.77B | ₹ -16.26B | ₹ -12.05B | |
| ₹ 6.94B | ₹ 7.07B | ₹ 6.32B | ₹ 3.55B | ₹ 6.25B | |
| ₹ 6.75B | ₹ 5.83B | ₹ 6.16B | ₹ 3.42B | ₹ 5.21B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 34.33 | ₹ 29.68 | ₹ 31.33 | ₹ 17.40 | ₹ 26.50 |
| Diluted EPS | ₹ 34.33 | ₹ 29.68 | ₹ 31.33 | ₹ 17.40 | ₹ 26.50 |
| Weighted Average Shares Outstanding | 196.55M | 196.56M | 196.56M | 196.56M | 196.56M |
| Weighted Average Shares Outstanding (Diluted) | 196.55M | 196.56M | 196.56M | 196.56M | 196.56M |
Currency in INR

